Looking for a clinical trial that's right for you?
Find a trialUCI Health, your source for clinical trials
UCI Health has one of Orange County’s largest clinical trials programs, with 1,000-plus trials and 3,450 patients enrolled in the past year. By participating in a clinical trial, you help shape the future of medicine. Help us discover and cure!
What are clinical trials?
Clinical trials evaluate the effects of new interventions on health.
Why participate?
Discovery depends on you!
Get involved!
Become a partner in discovering new clinical therapies.
Featured Trials
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study in Adults with Myasthenia Gravis
A Study to Evaluate the Efficacy, Safety, and Tolerability of 3 dose levels of NMD670 in Adult Patients with ACehR/MuSK-Ab+ Myasthenia Gravis
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
A Study to Evaluate the Safety and Efficacy of NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinson's Disease (NEULARK).
A study to evaluate the efficacy and safety of JCELL in patients with retinitis
The primary objective of this Phase 2/3 study is to evaluate the efficacy, safety and tolerability of a single intravitreal injection of jCell (famzeretcel) for the Treatment of Retinitis Pigmentosa (RP).
A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus.
This is a Phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants with moderate to severe active systemic lupus erythematosus (SLE). The study will consist of a dose-escalation stage, followed by an expansion stage to further evaluate the safety and activity of FT819.
Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo w/ SOC Tx for HPV+ Pts w/ HNSCC
This is a Phase 2, single-arm, open-label clinical trial determining safety and tolerability of AHCC in HPV-positive patients with Head and Neck Squamous Cell Carcinoma.
Repurposing Riluzole for Cancer-Related Cognitive Impairment: a Pilot Trial
A phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of Riluzole therapy on circulating brain derived neuropathic factor (BDNF) levels of breast cancer survivors with cancer related cognitive impairment.
Learn more about clinical trials at UCI Health
Explore valuable resources and support for all aspects of clinical trials at UCI health
UCI Research News
UCI Health enrolls patient in first U.S. study of medical device for erectile dysfunction
UCI Health has opened the first U.S. clinical trial of a novel radiofrequency device designed to treat erectile dysfunction (ED). Men's health specialist Dr. Faysal A. Yafi is leading the study of Vertica®, a device, designed and manufactured by Ohh-Med Ltd.
2024 Cancer Center Scientific Retreat
This retreat on Friday, November 8, 2024 is open to CFCCC members, clinicians, DOT leaders, shared resource teams, CHOC partners, community equity board members, established community partners, MET trainees, staff, postdoctoral trainees, graduate students and undergraduate students in cancer-related research labs.
Advancing regenerative medicine therapies
University and community guests recently gathered to celebrate the 7,700 square-foot Good Manufacturing Practice facility’s grand opening in Hewitt Hall’s basement on the UC Irvine campus.